Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

HIV Infection

Free Subscription 06.10.2025 13 AIDS 1 AIDS Res Hum Retroviruses 1 Antimicrob Agents Chemother 1 BMC Cancer 1 BMC Neurol 1 BMC Pediatr 3 Clin Infect Dis 3 HIV Med 1 J Acquir Immune Defic Syndr 1 J Clin Invest 1 J Immunol 4 J Infect Dis 1 J Med Virol 2 J Virol 1 Lancet 1 Lancet Infect Dis 1 Pediatr Infect Dis J 1 Pediatr Rev 1 PLoS Comput Biol 1 PLoS Med 9 PLoS One 1 PLoS Pathog 2 Proc Natl Acad Sci U S A 1 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. MARTIN-CARMONA J, Corona-Mata D, Tellez F, Navarrete Lorite MN, et al
   Long-term liver stiffness dynamics after sustained virological response in patients with HIV/HCV co-infection and advanced fibrosis.
   AIDS. 2025 Sep 24. doi: 10.1097/QAD.0000000000004357.
   PubMed         Abstract available
   
   
2. FISHER MC, Scherzer R, Postalcioglu M, Chen TK, et al
   Associations of repeated measures of plasma biomarkers of kidney tubular health with longitudinal kidney function in people with HIV.
   AIDS. 2025 Sep 24. doi: 10.1097/QAD.0000000000004359.
   PubMed         Abstract available
   
   
3. NIKOLOVA KA, Moller DL, Loft JA, Suarez-Zdunek MA, et al
   Association of Cytomegalovirus Immunoglobulin G Antibodies with Prevalent and De Novo Hypertension in People With HIV.
   AIDS. 2025 Sep 24. doi: 10.1097/QAD.0000000000004355.
   PubMed         Abstract available
   
   
4. ANDERSON K, Madlala HP, Nyemba DC, Dinkele R, et al
   Infectious morbidity among children HIV-exposed uninfected in South Africa: elevated risk in infancy but not thereafter.
   AIDS. 2025 Sep 24. doi: 10.1097/QAD.0000000000004358.
   PubMed         Abstract available
   
   
5. MOUCHERAUD C, Trujillo D, Wagner Z, Garland W, et al
   Preferences for HIV prevention conditional cash transfers among Black/African American and Latinx cisgender MSM in Los Angeles.
   AIDS. 2025 Sep 26. doi: 10.1097/QAD.0000000000004361.
   PubMed         Abstract available
   
   
6. SMITH MR, Cai R, Cote HCF
   Off target effects of HIV integrase strand transfer inhibitors in cell and animal models: a scoping review.
   AIDS. 2025;39:1849-1865.
   PubMed         Abstract available
   
   
7. MCHENRY MS, Masese ER, Kinyanjui D, Were E, et al
   Ethical considerations for research involving pregnant women with HIV and their children.
   AIDS. 2025;39:1866-1877.
   PubMed         Abstract available
   
   
8. MOSEHOLM E, Omland LH, Katzenstein TL, Pedersen G, et al
   Retention in care and viral suppression in pregnant/postpartum vs. nonpregnant/nonpostpartum women with HIV.
   AIDS. 2025;39:1936-1945.
   PubMed         Abstract available
   
   
9. VERA JH, Martinez E
   Reassuring evidence on statins and cognition in people with HIV.
   AIDS. 2025;39:1970-1971.
   PubMed        
   
   
10. GHANOONI D, Heise MJ, Sassaman K, Glidden DV, et al
    Suboptimal ART adherence, undetectable urine tenofovir, and higher C-reactive protein values.
    AIDS. 2025;39:1975-1978.
    PubMed         Abstract available
    
    
11. BENZEKRI NA, Sambou JF, Diedhiou Y, Sagna ML, et al
    Partnering with traditional healers to increase HIV testing in Senegal, West Africa.
    AIDS. 2025;39:1978-1981.
    PubMed         Abstract available
    
    
12. SEWACK AB, Manning MR, Blazkova J, Justement JS, et al
    Correlations among quantitative assays that measure the size of HIV reservoirs in people with HIV receiving antiretroviral therapy.
    AIDS. 2025;39:1982-1984.
    PubMed        
    
    
13. CARR A, Mngqibisa R, Khaertynova I, Kumar PN, et al
    Efficacy and safety of doravirine/islatravir in heavily treatment-experienced participants living with HIV-1 from a randomized trial.
    AIDS. 2025 Oct 2. doi: 10.1097/QAD.0000000000004367.
    PubMed         Abstract available
    
    

    
    AIDS Res Hum Retroviruses

14. CHEN M, Ma Y, Chen H, Jia M, et al
    Identification of an Emerging HIV-1B/C Circulating Recombinant Form (CRF176_BC) in Heterosexual Populations in Yunnan Province, China.
    AIDS Res Hum Retroviruses. 2025 Sep 26. doi: 10.1177/08892229251382841.
    PubMed         Abstract available
    
    

    
    Antimicrob Agents Chemother

15. TSIRIZANI L, Waalewijn H, Szubert A, Mulenga V, et al
    Population pharmacokinetics of ritonavir as a booster of lopinavir, atazanavir, or darunavir in African children with HIV.
    Antimicrob Agents Chemother. 2025 Sep 26:e0077125. doi: 10.1128/aac.00771.
    PubMed         Abstract available
    
    

    
    BMC Cancer

16. BANDALA-JACQUES A, Saldanha IJ, D'Souza G
    Oropharyngeal cancer risk groups in the United States: a meta-analysis and SEER analysis.
    BMC Cancer. 2025;25:1441.
    PubMed         Abstract available
    
    

    
    BMC Neurol

17. HIRANSUTHIKUL A, Taweephol T, Timachai N, Suksawek S, et al
    The validity of computerized Montreal cognitive assessment among aging people living with HIV: A pilot study.
    BMC Neurol. 2025;25:406.
    PubMed         Abstract available
    
    

    
    BMC Pediatr

18. VREEMAN RC, Yiannoutsos CT, Edmonds A, Leroy V, et al
    Rates of adherence, adherence measurement, and support services for children and adolescents living with HIV followed in global sites of the International Epidemiology Databases to Evaluate AIDS (IeDEA).
    BMC Pediatr. 2025;25:706.
    PubMed         Abstract available
    
    

    
    Clin Infect Dis

19. MARTINEZ MARTIN P, Esteban-Cantos A, Jurado F, Montejano R, et al
    Prognostic value of blood epigenetic biomarkers of aging in persons with well controlled HIV infection.
    Clin Infect Dis. 2025 Sep 30:ciaf537. doi: 10.1093.
    PubMed         Abstract available
    
    
20. DURSTENFELD MS
    REPRIEVE Analysis of New Cardiovascular Risk Calculators in HIV: Underpredicting Risk Means Preventing Fewer Heart Attacks.
    Clin Infect Dis. 2025 Sep 26:ciaf543. doi: 10.1093.
    PubMed        
    
    
21. GRINSPOON SK, Zhao S, Martinez E, Fichtenbaum CJ, et al
    Risk Assessment in a Global CVD Prevention Cohort of People with HIV by PCE, PREVENT, and SCORE2.
    Clin Infect Dis. 2025 Sep 26:ciaf542. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    HIV Med

22. TWABI HH, Ueno A, Ives J, Murtagh R, et al
    Diagnostic accuracy of the WHO clinical staging system for detection of immunologically defined advanced HIV disease: A systematic review and meta-analysis.
    HIV Med. 2025 Sep 26. doi: 10.1111/hiv.70122.
    PubMed         Abstract available
    
    
23. GAROFOLI N, Flandre P, Vincensini JP, Richier Q, et al
    Impact on weight of a Doravirine switch in people living with HIV.
    HIV Med. 2025 Sep 30. doi: 10.1111/hiv.70123.
    PubMed         Abstract available
    
    
24. BARRE T, Ramier C, Protopopescu C, Sogni P, et al
    Perceived disabling physical pain and suicidal ideation in aging people living with HIV cured of hepatitis C: A multi-center survey in France (ANRS CO13 HEPAVIH).
    HIV Med. 2025 Oct 1. doi: 10.1111/hiv.70121.
    PubMed         Abstract available
    
    

    
    J Acquir Immune Defic Syndr

25. VYAS KJ, Moreland S, Esser S, Jessen H, et al
    Trends in Online and In-Person Sex-Seeking Venues among Men who have Sex with Men in Berlin, Germany.
    J Acquir Immune Defic Syndr. 2025 Sep 25. doi: 10.1097/QAI.0000000000003766.
    PubMed         Abstract available
    
    

    
    J Clin Invest

26. ARCHIN NM
    A die is cast: autologous neutralizing antibody resistance shapes the HIV reservoir during uninterrupted ART.
    J Clin Invest. 2025;135:e198353.
    PubMed         Abstract available
    
    

    
    J Immunol

27. FERRE AL, Fehrman EA, Hunt PW, Somsouk M, et al
    Gastrointestinal MAIT cells in chronic HIV-1 infection.
    J Immunol. 2025 Sep 30:vkaf266. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Infect Dis

28. KELLY C, Lester JS, Bradshaw D, Bibby DF, et al
    Real-world prevalence of non-integrase INSTI resistance-associated mutations and virological outcomes in people who have recently acquired HIV-1 in the UK.
    J Infect Dis. 2025 Sep 26:jiaf500. doi: 10.1093.
    PubMed         Abstract available
    
    
29. BOARDMAN SA, Hetherington C, Hughes T, Cook C, et al
    Viral Infection and the Blood-Brain Barrier: Molecular Research Insights and Therapies.
    J Infect Dis. 2025 Sep 29:jiaf455. doi: 10.1093.
    PubMed         Abstract available
    
    
30. HIRANBURANA N, Sophonphan J, Kerr SJ, Ubolyam S, et al
    NAT2 polymorphisms and Antituberculosis-Induced Hepatotoxicity in Thai People Living with HIV: Insights from a Pharmacogenetic-Pharmacokinetic Cohort Study.
    J Infect Dis. 2025 Oct 1:jiaf511. doi: 10.1093.
    PubMed         Abstract available
    
    
31. COHEN C, Moore P
    Mechanistic insights into increased vulnerability to respiratory infections in HIV-Exposed Uninfected Infants.
    J Infect Dis. 2025 Sep 30:jiaf494. doi: 10.1093.
    PubMed        
    
    

    
    J Med Virol

32. SHI S, Zhai M, Wu B, Sun W, et al
    Mitochondrial Disruption in Viral-Mediated Neuronal Injury: A Mechanistic Perspective.
    J Med Virol. 2025;97:e70626.
    PubMed         Abstract available
    
    

    
    J Virol

33. VACA CC, Hudson H, Clerc I, Song C, et al
    HIV proviral transcription and infectivity are enhanced by neddylation.
    J Virol. 2025 Sep 30:e0096825. doi: 10.1128/jvi.00968.
    PubMed         Abstract available
    
    
34. BRANT AC, Hu Z, Chen AZ, Majerciak V, et al
    Discontinuous template switching generates coronavirus subgenomic RNAs from the 3' viral genome end by 5' to 3' transcription.
    J Virol. 2025 Sep 25:e0143825. doi: 10.1128/jvi.01438.
    PubMed         Abstract available
    
    

    
    Lancet

35. 
    The global, regional, and national burden of cancer, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023.
    Lancet. 2025 Sep 24:S0140-6736(25)01635-6. doi: 10.1016/S0140-6736(25)01635.
    PubMed         Abstract available
    
    

    
    Lancet Infect Dis

36. SEDDON JA, Achar J, Malik AA, Hughes J, et al
    Management of individuals exposed to multidrug-resistant or rifampicin-resistant tuberculosis.
    Lancet Infect Dis. 2025 Jun 5:S1473-3099(25)00157.
    PubMed         Abstract available
    
    

    
    Pediatr Infect Dis J

37. MORAA H, Njuguna IN, Mburu C, John-Stewart G, et al
    Missed Opportunities to Prevent Mortality Among Youth Living With HIV: Insights From Verbal Autopsies and Clinical Record Reviews.
    Pediatr Infect Dis J. 2025 Sep 26. doi: 10.1097/INF.0000000000005005.
    PubMed         Abstract available
    
    

    
    Pediatr Rev

38. QURESHI NK, Rathore MH
    Aminoglycosides.
    Pediatr Rev. 2025;46:589-592.
    PubMed        
    
    

    
    PLoS Comput Biol

39. MULLER NF, Bouckaert RR, Wu CH, Bedford T, et al
    MASCOT-Skyline integrates population and migration dynamics to enhance phylogeographic reconstructions.
    PLoS Comput Biol. 2025;21:e1013421.
    PubMed         Abstract available
    
    

    
    PLoS Med

40. SKRIVANKOVA VW, Rabie S, Tlali M, Folb N, et al
    Incidence and prognostic factors of self-harm and subsequent unnatural death in South Africa: A cohort study.
    PLoS Med. 2025;22:e1004765.
    PubMed         Abstract available
    
    

    
    PLoS One

41. NEGASH WD, Belachew TB, Jejaw M, Tiruneh MG, et al
    Misconception about HIV/AIDS transmission among sexually active women in emerging regions of Ethiopia.
    PLoS One. 2025;20:e0331466.
    PubMed         Abstract available
    
    
42. MURENZI G, Kanyabwisha F, Demarco M, Muhoza B, et al
    Determinants of cervical high-risk human papillomavirus positivity among Rwandan women living with human immunodeficiency virus.
    PLoS One. 2025;20:e0333077.
    PubMed         Abstract available
    
    
43. DOMINGUEZ A, Torner N, Soldevila N, Varela C, et al
    Hepatitis A in Spain: Evolution of hospitalization in the period 2000-2021.
    PLoS One. 2025;20:e0332317.
    PubMed         Abstract available
    
    
44. SHAMU P, Christofides NJ, Mullick S
    Facilitators and barriers to contraceptive uptake and use: Perspectives of female students in South Africa and lessons for quality provision of HIV pre-exposure prophylaxis.
    PLoS One. 2025;20:e0333270.
    PubMed         Abstract available
    
    
45. UDOH EE, Musa AZ, Olowolafe TA, Obi CO, et al
    Antiretroviral treatment outcomes and survival pattern of people living with HIV in Bauchi State, Nigeria.
    PLoS One. 2025;20:e0333106.
    PubMed         Abstract available
    
    
46. ATHANAS R, Paulo HA, Frumence G, Iseselo MK, et al
    Does financial compensation matter for research participation in prevention trials in Tanzania? Perspectives of healthy volunteers.
    PLoS One. 2025;20:e0321353.
    PubMed         Abstract available
    
    
47. QIAO S, Aggarwal A, Garrett C, N'Diaye A, et al
    Sleep quality, emotional moods, and cognitive outcomes among people living with HIV: An ecological momentary assessment study.
    PLoS One. 2025;20:e0329399.
    PubMed         Abstract available
    
    
48. NAMBUYA H, Mupere E, Nabukeera-Barungi N, Mubiri P, et al
    Prevalence, incidence and associated factors of pneumonia among severely malnourished children hospitalized in Mulago National Referral Hospital, Uganda.
    PLoS One. 2025;20:e0331698.
    PubMed         Abstract available
    
    
49. TARKANG EE, Manu E, Aku FY, Komesuor J, et al
    Healthcare providers' experiences and recommendations for antiretroviral therapy adherence in Ghana: A facility-based phenomenological study.
    PLoS One. 2025;20:e0333695.
    PubMed         Abstract available
    
    

    
    PLoS Pathog

50. DERBY N, Johnson BI, Biswas S, Fischer M, et al
    Liver biopsies obtained throughout SIV infection reveal evolving interferon stimulated protein expression within distinct monocyte/macrophage subsets.
    PLoS Pathog. 2025;21:e1013175.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

51. KIM S, Travisano KA, Wilder B, Palomares M, et al
    Exceptionally broad HIV-1 neutralization via bispecific antibody-mediated prepositioning.
    Proc Natl Acad Sci U S A. 2025;122:e2517311122.
    PubMed         Abstract available
    
    
52. LIU Y, Li P, Zheng YM, Hikichi Y, et al
    IFN-inducible human phospholipid scramblase 1 (PLSCR1) protein restricts HIV-1 infection by inhibiting membrane fusion.
    Proc Natl Acad Sci U S A. 2025;122:e2516527122.
    PubMed         Abstract available
    
    

    
    Vaccine

53. VAN SCHALKWYK C, Meyer-Rath G, Masuku S, Jamieson L, et al
    Cost-effectiveness of different HPV vaccination strategies for cervical cancer prevention in South Africa.
    Vaccine. 2025;64:127770.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.